Skocz do pozycji: 1.

Tytuł:

Aggressive Lymphoplasmacytic Neoplasm With an Unusual In-frame Deletion of MYD88 Associated With TRAF3 and TP53 Mutations and Complex Karyotype.

Autorzy:

Yan M; Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
Meyerson H; Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
Oduro KA; Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
Shetty S; Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
Yoest J; Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.

Pokaż więcej

Źródło:

International journal of surgical pathology [Int J Surg Pathol] 2024 Feb; Vol. 32 (1), pp. 5-10. Date of Electronic Publication: 2023 Apr 24.

Typ publikacji:

Journal Article

MeSH Terms:

Lymphoma, B-Cell, Marginal Zone*/pathology
Waldenstrom Macroglobulinemia*/diagnosis
Waldenstrom Macroglobulinemia*/genetics
Waldenstrom Macroglobulinemia*/pathology
Humans ; Myeloid Differentiation Factor 88/genetics ; TNF Receptor-Associated Factor 3/genetics ; NF-kappa B/genetics ; Mutation ; Karyotype ; Tumor Suppressor Protein p53/genetics

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 2.

Tytuł:

A Rare Case of Non-IgM Lymphoplasmacytic Lymphoma with Unusual Lack of Immunoglobulin Light Chain Production.

Autorzy:

Yin J; Department of Pathology, Temple University Hospital, Philadelphia, PA, USA.
Bains A; Department of Pathology, Temple University Hospital, Philadelphia, PA, USA.
Alsammak M; Department of Pathology, Temple University Hospital, Philadelphia, PA, USA.
Fu JJ; Department of Pathology, Temple University Hospital, Philadelphia, PA, USA.

Pokaż więcej

Źródło:

The American journal of case reports [Am J Case Rep] 2024 Mar 04; Vol. 25, pp. e940963. Date of Electronic Publication: 2024 Mar 04.

Typ publikacji:

Case Reports; Journal Article

MeSH Terms:

Waldenstrom Macroglobulinemia*/diagnosis
Lymphoma, B-Cell*
Lymphoma*
Female ; Humans ; Aged ; Immunoglobulin A ; Immunoglobulin G

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 3.

Tytuł:

A Rare Case of Subcutaneous Amyloidoma Associated with Localized Lymphoplasmacytic Lymphoma: Diagnostic Challenges and Treatment Considerations.

Autorzy:

Vivian LF; Department of Pathology, ASST Santi Paolo e Carlo, Milan, Italy.
Marcelis L; Department of Pathology, UZ Leuven, University Hospitals, Leuven, Belgium.; Department of Imaging and Pathology, Translational Cell and Tissue Research Lab, KU Leuven, Leuven, Belgium.
Leoni E; Department of Pathology, ASST Valle Olona, Busto Arsizio, Italy.
De Bruecker Y; Department of Radiology, Imelda Hospital, Bonheiden, Belgium.
Maes H; Department of Hematology, Imelda Hospital, Bonheiden, Belgium.
Pierré E; Department of Pathology, Imelda Hospital, Bonheiden, Belgium.
Ballaux FM; Department of Pathology, Imelda Hospital, Bonheiden, Belgium.
Tousseyn T; Department of Pathology, UZ Leuven, University Hospitals, Leuven, Belgium.; Department of Imaging and Pathology, Translational Cell and Tissue Research Lab, KU Leuven, Leuven, Belgium.

Pokaż więcej

Źródło:

The American journal of case reports [Am J Case Rep] 2023 Oct 02; Vol. 24, pp. e940789. Date of Electronic Publication: 2023 Oct 02.

Typ publikacji:

Review; Case Reports; Journal Article

MeSH Terms:

Amyloidosis*/diagnosis
Amyloidosis*/therapy
Lymphoma, B-Cell, Marginal Zone*/diagnosis
Lymphoma, B-Cell, Marginal Zone*/therapy
Waldenstrom Macroglobulinemia*/complications
Waldenstrom Macroglobulinemia*/diagnosis
Waldenstrom Macroglobulinemia*/therapy
Plasmacytoma*/diagnosis
Plasmacytoma*/therapy
Soft Tissue Neoplasms*
Female ; Humans ; Middle Aged ; Amyloid

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 4.

Tytuł:

Hematological entities with plasmacytic differentiation: a case report.

Autorzy:

Inamdar A; Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA, 19104-4238, USA. .
Bhattacharyya S; Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA, 19104-4238, USA.

Pokaż więcej

Źródło:

Journal of medical case reports [J Med Case Rep] 2023 Sep 26; Vol. 17 (1), pp. 429. Date of Electronic Publication: 2023 Sep 26.

Typ publikacji:

Case Reports; Journal Article

MeSH Terms:

Plasmacytoma*/diagnosis
Waldenstrom Macroglobulinemia*/diagnosis
Female ; Humans ; Middle Aged ; In Situ Hybridization, Fluorescence ; Immunoglobulin M ; Cell Differentiation

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 5.

Tytuł:

Ibrutinib-Induced Pancreatitis in Patients with Waldenstrom Macroglobulinemia

Autorzy:

Büyükkurt N; Başkent University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Ankara, Türkiye
Soydaş B; Başkent University Faculty of Medicine, Department of Gastroenterology, Ankara, Türkiye

Pokaż więcej

Źródło:

Turkish journal of haematology : official journal of Turkish Society of Haematology [Turk J Haematol] 2023 May 29; Vol. 40 (2), pp. 141-142. Date of Electronic Publication: 2023 May 17.

Typ publikacji:

Journal Article

MeSH Terms:

Waldenstrom Macroglobulinemia*/complications
Waldenstrom Macroglobulinemia*/drug therapy
Humans ; Piperidines/adverse effects ; Agammaglobulinaemia Tyrosine Kinase ; Adenine/adverse effects

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 6.

Tytuł:

Waldenström macroglobulinemia with secondary pure red cell aplasia in a patient with metastatic castrate resistant prostate cancer receiving an immune checkpoint inhibitor: a case report.

Autorzy:

Kumar V; Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Division of Oncology, Department of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Chapel Hill, NC, 27599-7305, USA.
Montgomery ND; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
van Deventer HW; Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Whang YE; Division of Oncology, Department of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Chapel Hill, NC, 27599-7305, USA. .; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. .

Pokaż więcej

Źródło:

Journal of medical case reports [J Med Case Rep] 2023 May 28; Vol. 17 (1), pp. 220. Date of Electronic Publication: 2023 May 28.

Typ publikacji:

Case Reports; Journal Article

MeSH Terms:

Waldenstrom Macroglobulinemia*/complications
Waldenstrom Macroglobulinemia*/drug therapy
Red-Cell Aplasia, Pure*/chemically induced
Red-Cell Aplasia, Pure*/drug therapy
Red-Cell Aplasia, Pure*/complications
Anemia*/chemically induced
Prostatic Neoplasms*/complications
Lymphoproliferative Disorders*
Humans ; Male ; Aged ; Immune Checkpoint Inhibitors

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 7.

Tytuł:

Mycoplasma infection mimicking a malignancy in a waldenstrom macroglobulinemia patient.

Autorzy:

Wu J; Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310000, China.; Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, 310000, China.
He D; Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310000, China.; Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, 310000, China.
Yu F; Department of Pathology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310000, China.
Huang Y; Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310000, China.
Bian M; Department of Hematology, The Second People's Hospital of Huai'an, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huaian, 223001, China.
Yu C; Department of Colorectal Surgery and Oncology, Key Laboratory of Cancer Prevention and Intervention, The Second Affiliated Hospital, Ministry of Education, Zhejiang University School of Medicine, Hangzhou, 310000, Zhejiang, China.
Liu J; Hangzhou Xixi Hospital, Zhejiang University of Traditional Chinese Medicine, Hangzhou, 310000, Zhejiang, China.
Cai Z; Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310000, China.; Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, 310000, China.; Institute of Hematology, Zhejiang University, Hangzhou, 310000, Zhejiang, China.; Zhejiang Laboratory for Systems & Precision Medicine, Zhejiang University Medical Center, Hangzhou, 310000, China.
Zhao Y; Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310000, China. .; Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, 310000, China. .

Pokaż więcej

Źródło:

BMC infectious diseases [BMC Infect Dis] 2023 Apr 07; Vol. 23 (1), pp. 219. Date of Electronic Publication: 2023 Apr 07.

Typ publikacji:

Case Reports; Journal Article

MeSH Terms:

Urinary Bladder Neoplasms*
Waldenstrom Macroglobulinemia*/diagnosis
Humans ; Fluorodeoxyglucose F18 ; Positron Emission Tomography Computed Tomography/methods ; Positron-Emission Tomography ; Radiopharmaceuticals ; Diagnosis, Differential ; Neoplasms

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 8.

Tytuł:

Bilateral central retinal vein occlusion as an initial presentation of Waldenström macroglobulinemia: a case report.

Autorzy:

Shrestha S; Maharajgunj Medical Campus, Institute of Medicine, Kathmandu, Nepal. .
Poddar E; Maharajgunj Medical Campus, Institute of Medicine, Kathmandu, Nepal.
Bashyal B; Department of Internal Medicine, Tribhuvan University Teaching Hospital, Kathmandu, Nepal.
Adhikari A; Maharajgunj Medical Campus, Institute of Medicine, Kathmandu, Nepal.
Pathak P; Department of Pathology, Tribhuvan University Teaching Hospital, Kathmandu, Nepal.
Acharya S; Department of Internal Medicine, Tribhuvan University Teaching Hospital, Kathmandu, Nepal.
Sapkota S; Department of Internal Medicine, Saint Agnes Hospital, Maryland, USA.
Bhattarai A; Maharajgunj Medical Campus, Institute of Medicine, Kathmandu, Nepal.
Pant SR; Maharajgunj Medical Campus, Institute of Medicine, Kathmandu, Nepal.
Shrestha A; Department of Pathology, Tribhuvan University Teaching Hospital, Kathmandu, Nepal.

Pokaż więcej

Źródło:

Journal of medical case reports [J Med Case Rep] 2023 Feb 20; Vol. 17 (1), pp. 59. Date of Electronic Publication: 2023 Feb 20.

Typ publikacji:

Case Reports; Journal Article

MeSH Terms:

Waldenstrom Macroglobulinemia*/complications
Waldenstrom Macroglobulinemia*/diagnosis
Waldenstrom Macroglobulinemia*/drug therapy
Retinal Vein Occlusion*/diagnosis
Retinal Vein Occlusion*/drug therapy
Retinal Vein Occlusion*/etiology
Humans ; Male ; Adult ; Bortezomib

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 9.

Tytuł:

Patient preferences regarding treatment options for Waldenström's macroglobulinemia: A discrete choice experiment.

Autorzy:

Amaador K; Amsterdam UMC, University of Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Amsterdam, The Netherlands.
Nieuwkerk PT; Department of Medical Psychology, Academic Medical Center, Amsterdam, The Netherlands.
Minnema MC; Department of Hematology, University Medical Center Utrecht, University Utrecht, Utrecht, The Netherlands.
Kersten MJ; Amsterdam UMC, University of Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Amsterdam, The Netherlands.
Vos JMI; Amsterdam UMC, University of Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Amsterdam, The Netherlands.

Pokaż więcej

Źródło:

Cancer medicine [Cancer Med] 2023 Feb; Vol. 12 (3), pp. 3376-3386. Date of Electronic Publication: 2022 Jul 26.

Typ publikacji:

Journal Article

MeSH Terms:

Waldenstrom Macroglobulinemia*/therapy
Peripheral Nervous System Diseases*
Humans ; Patient Preference ; Nausea ; Vomiting

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 10.

Tytuł:

Treatment of relapsed and refractory Waldenstrom Macroglobulinemia.

Autorzy:

Amaador K; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Kersten MJ; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Minnema MC; Department of Hematology, University Medical Center Utrecht, University Utrecht, Utrecht, The Netherlands.
Vos JMI; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Pokaż więcej

Źródło:

Leukemia & lymphoma [Leuk Lymphoma] 2023 Jan; Vol. 64 (1), pp. 30-41. Date of Electronic Publication: 2022 Oct 25.

Typ publikacji:

Journal Article

MeSH Terms:

Waldenstrom Macroglobulinemia*/drug therapy
Waldenstrom Macroglobulinemia*/genetics
Antineoplastic Agents*/therapeutic use
Lymphoma, Non-Hodgkin*/drug therapy
Humans ; Antibodies, Monoclonal/therapeutic use ; Mutation ; Myeloid Differentiation Factor 88/genetics

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 11.

Tytuł:

Single-cell profiles reveal tumor cell heterogeneity and immunosuppressive microenvironment in Waldenström macroglobulinemia.

Autorzy:

Sun H; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.; Tianjin Institutes of Health Science, Tianjin, 301600, China.
Fang T; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.; Tianjin Institutes of Health Science, Tianjin, 301600, China.
Wang T; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
Yu Z; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.; Tianjin Institutes of Health Science, Tianjin, 301600, China.
Gong L; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.; Tianjin Institutes of Health Science, Tianjin, 301600, China.
Wei X; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
Wang H; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
He Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
Liu L; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.; Tianjin Institutes of Health Science, Tianjin, 301600, China.
Yan Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
Sui W; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
Xu Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
Yi S; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
Qiu L; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China. .; Tianjin Institutes of Health Science, Tianjin, 301600, China. .
Hao M; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China. .; Tianjin Institutes of Health Science, Tianjin, 301600, China. .

Pokaż więcej

Źródło:

Journal of translational medicine [J Transl Med] 2022 Dec 09; Vol. 20 (1), pp. 576. Date of Electronic Publication: 2022 Dec 09.

Typ publikacji:

Journal Article; Research Support, Non-U.S. Gov't

MeSH Terms:

Ecosystem*
Waldenstrom Macroglobulinemia*/genetics
Waldenstrom Macroglobulinemia*/pathology
Humans ; Bone Marrow/pathology ; Tumor Microenvironment ; B-Lymphocytes/pathology

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 12.

Tytuł:

Successful and safe response to ibrutinib alone in treating relapsed Waldenström macrogobulinemia and related acquired von Willebrand syndrome: an option to consider.

Autorzy:

Butelet A; Hemostasis and transfusion department, Biology Pathology Center, University hospital of Lille, Lille, France.
Poulain S; Laboratory of Hematology, Biology Pathology Center, CHU of Lille, INSERM UMR-S 1177, Team 4, Cancer Research Institute, Univ. Lille, France.
Jeanpierre E; Hemostasis and transfusion department, Biology Pathology Center, University hospital of Lille, Lille, France.
Srour M; Service des Maladies du Sang, Centre Hospitalier Universitaire de Lille, Lille, France.
Nudel M; Service des Maladies du Sang, Centre Hospitalier Universitaire de Lille, Lille, France.
Chauvet P; Service des Maladies du Sang, Centre Hospitalier Universitaire de Lille, Lille, France.
Bauters A; Hemostasis and transfusion department, Biology Pathology Center, University hospital of Lille, Lille, France.
Susen S; Hemostasis and transfusion department, Biology Pathology Center, University hospital of Lille, Lille, France.
Dupont A; Hemostasis and transfusion department, Biology Pathology Center, University hospital of Lille, Lille, France.
de Charette M; Service des Maladies du Sang, Centre Hospitalier Universitaire de Lille, Lille, France.; Service d'hématologie, Centre Hospitalier Universitaire de la Réunion, Saint Denis, France.

Pokaż więcej

Źródło:

Leukemia & lymphoma [Leuk Lymphoma] 2022 Dec; Vol. 63 (13), pp. 3100-3104. Date of Electronic Publication: 2022 Sep 13.

Typ publikacji:

Journal Article

MeSH Terms:

von Willebrand Diseases*/diagnosis
von Willebrand Diseases*/drug therapy
von Willebrand Diseases*/etiology
Waldenstrom Macroglobulinemia*/complications
Waldenstrom Macroglobulinemia*/diagnosis
Waldenstrom Macroglobulinemia*/drug therapy
Humans ; Neoplasm Recurrence, Local ; Piperidines/therapeutic use

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 13.

Tytuł:

Successful Management of Ibrutinib-Induced Thrombocytopenia with Eltrombopag in a Patient with Waldenström Macroglobulinemia

Autorzy:

Erçalışkan A; Düzce Atatürk State Hospital, Department of Internal Medicine, Division of Hematology, Düzce, Turkey
Avcı FZ; İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, Department of Internal Medicine, İstanbul, Turkey
Eşkazan AE; İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, Department of Internal Medicine, Division of Hematology, İstanbul, Turkey

Pokaż więcej

Źródło:

Turkish journal of haematology : official journal of Turkish Society of Haematology [Turk J Haematol] 2022 Dec 01; Vol. 39 (4), pp. 275-276. Date of Electronic Publication: 2022 Nov 14.

Typ publikacji:

Journal Article

MeSH Terms:

Waldenstrom Macroglobulinemia*/complications
Waldenstrom Macroglobulinemia*/drug therapy
Thrombocytopenia*/chemically induced
Thrombocytopenia*/drug therapy
Humans ; Pyrazoles/adverse effects

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 14.

Tytuł:

A fatal case of a CD5-positive lymphoplasmacytic lymphoma with associated AL-type amyloidosis.

Autorzy:

Marchand A; Department of Pathology, Naval Medical Center, San Diego, California, USA.
Swalchick WG; Department of Pathology, University of California San Diego Health System, La Jolla, California, USA.; Department of Pathology, Trinity Health, Charleston, South Carolina, USA.
Wang HY; Department of Pathology, University of California San Diego Health System, La Jolla, California, USA.

Pokaż więcej

Źródło:

International journal of laboratory hematology [Int J Lab Hematol] 2022 Dec; Vol. 44 (6), pp. 995-996. Date of Electronic Publication: 2022 May 21.

Typ publikacji:

Case Reports

MeSH Terms:

Lymphoma, B-Cell*/pathology
Waldenstrom Macroglobulinemia*/complications
Waldenstrom Macroglobulinemia*/diagnosis
Immunoglobulin Light-chain Amyloidosis*/complications
Immunoglobulin Light-chain Amyloidosis*/diagnosis
Humans

Raport

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 15.

Tytuł:

The unpredictable erythrocyte deformability alteration in some hematological disorders: How the classification of primary hyperviscosity syndromes could change.

Autorzy:

Caimi G; Department of Health Promotion and Child Care, Internal Medicine and Medical Specialties, Università degli Studi di Palermo, Palermo, Italy.
Carlisi M; Department of Health Promotion and Child Care, Internal Medicine and Medical Specialties, Università degli Studi di Palermo, Palermo, Italy.

Pokaż więcej

Źródło:

Clinical hemorheology and microcirculation [Clin Hemorheol Microcirc] 2023; Vol. 83 (4), pp. 341-349.

Typ publikacji:

Journal Article

MeSH Terms:

Polycythemia Vera*/genetics
Hematologic Diseases*
Paraproteinemias*
Waldenstrom Macroglobulinemia*
Humans ; Erythrocyte Deformability ; Blood Viscosity ; Syndrome

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 16.

Tytuł:

Insurance-based disparities impact survival outcomes in Waldenström macroglobulinemia within the United States.

Autorzy:

Chohan KL; Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Abeykoon JP; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Ansell SM; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Gertz MA; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Kapoor P; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Paulus A; Division of Hematology, Mayo Clinic, Jacksonville, FL, USA.
Ailawadhi S; Division of Hematology, Mayo Clinic, Jacksonville, FL, USA.
Reeder CB; Division of Hematology, Mayo Clinic, Phoenix, AZ, USA.
Witzig TE; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Habermann TM; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Lacy MQ; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Kyle RA; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Go RS; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Paludo J; Division of Hematology, Mayo Clinic, Rochester, MN, USA.

Pokaż więcej

Źródło:

Leukemia & lymphoma [Leuk Lymphoma] 2022 Dec; Vol. 63 (12), pp. 2879-2888. Date of Electronic Publication: 2022 Jul 23.

Typ publikacji:

Journal Article

MeSH Terms:

Medicare*
Waldenstrom Macroglobulinemia*
United States/epidemiology ; Humans ; Male ; Aged ; Middle Aged ; Insurance Coverage ; Medically Uninsured ; Medicaid ; Healthcare Disparities ; Insurance, Health

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 17.

Tytuł:

Coming of Age for BTK Inhibitor Therapy: A Review of Zanubrutinib in Waldenström Macroglobulinemia.

Autorzy:

Muñoz J; Department of Hematology, Mayo Clinic, Phoenix, AZ 85054, USA.
Paludo J; Department of Hematology, Mayo Clinic, Rochester, MN 55905, USA.
Sarosiek S; Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
Castillo JJ; Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.

Pokaż więcej

Źródło:

Cells [Cells] 2022 Oct 19; Vol. 11 (20). Date of Electronic Publication: 2022 Oct 19.

Typ publikacji:

Journal Article; Review; Research Support, Non-U.S. Gov't

MeSH Terms:

Waldenstrom Macroglobulinemia*/drug therapy
Waldenstrom Macroglobulinemia*/genetics
Waldenstrom Macroglobulinemia*/pathology
Lymphoma, B-Cell*
Humans ; Agammaglobulinaemia Tyrosine Kinase ; Quality of Life ; Protein Kinase Inhibitors/adverse effects

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 18.

Tytuł:

A Canadian Perspective on the Treatment of Waldenström Macroglobulinemia.

Autorzy:

Kaedbey R; Department of Hematology, Jewish General Hospital, Montreal, QC H3T 1E2, Canada.
Forward N; Department of Medicine, Dalhousie University/Nova Scotia Health, Halifax, NS B3H 2Y9, Canada.
Sehn LH; Department of Medical Oncology, BC Cancer Centre for Lymphoid Cancer, Vancouver, BC V5Z 4E6, Canada.
Shafey M; Department of Medicine, Division of Hematology, Foothills Medical Centre and University of Calgary, Calgary, AB T2N 2T9, Canada.
Doucette S; Impact Medicom Inc., Toronto, ON M6S 3K2, Canada.
Chen CI; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 610 University Avenue, Suite 6-225, Toronto, ON M5G 2M9, Canada.

Pokaż więcej

Źródło:

Current oncology (Toronto, Ont.) [Curr Oncol] 2022 Sep 28; Vol. 29 (10), pp. 7122-7139. Date of Electronic Publication: 2022 Sep 28.

Typ publikacji:

Journal Article; Research Support, Non-U.S. Gov't

MeSH Terms:

Waldenstrom Macroglobulinemia*/drug therapy
Waldenstrom Macroglobulinemia*/diagnosis
Hematopoietic Stem Cell Transplantation*
Humans ; Rituximab/therapeutic use ; Bendamustine Hydrochloride/therapeutic use ; Agammaglobulinaemia Tyrosine Kinase ; Proteasome Inhibitors/therapeutic use ; Quality of Life ; Transplantation, Autologous ; Canada ; Immunoglobulin M/therapeutic use ; Purines/therapeutic use

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 19.

Tytuł:

Waldenström Macroglobulinemia: Mechanisms of Disease Progression and Current Therapies.

Autorzy:

Boutilier AJ; Department of Molecular, Cellular and Biomedical Sciences, University of New Hampshire, Durham, NH 03824, USA.
Huang L; Phillips Exeter Academy, Exeter, NH 03833, USA.
Elsawa SF; Department of Molecular, Cellular and Biomedical Sciences, University of New Hampshire, Durham, NH 03824, USA.

Pokaż więcej

Źródło:

International journal of molecular sciences [Int J Mol Sci] 2022 Sep 22; Vol. 23 (19). Date of Electronic Publication: 2022 Sep 22.

Typ publikacji:

Journal Article; Review

MeSH Terms:

Lymphoma, B-Cell*/pathology
Waldenstrom Macroglobulinemia*/drug therapy
Waldenstrom Macroglobulinemia*/pathology
Bone Marrow/pathology ; Cytokines/therapeutic use ; Disease Progression ; Humans ; Tumor Microenvironment

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 20.

Tytuł:

Mu heavy chain disease with MYD88 L265P mutation: an unusual manifestation of lymphoplasmacytic lymphoma.

Autorzy:

Baloda V; Department of Pathology, UPMC, Pittsburgh, PA, USA.
Wheeler SE; Department of Pathology, University of Pittsburgh and UPMC, Pittsburgh, PA, USA.
Murray DL; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Kohlhagen MC; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Vos JA; Department of Pathology, Anatomy and Laboratory Medicine, West Virginia University, Morgantown, WV, USA.
Yatsenko SA; Department of Pathology, University of Pittsburgh and UPMC, Pittsburgh, PA, USA.
Agha ME; Hillman Cancer Center, University of Pittsburgh and UPMC, Pittsburgh, PA, USA.
Djokic M; Department of Pathology, University of Pittsburgh and UPMC, Pittsburgh, PA, USA.
Swerdlow SH; Department of Pathology, University of Pittsburgh and UPMC, Pittsburgh, PA, USA.
Bailey NG; Department of Pathology, University of Pittsburgh and UPMC, Pittsburgh, PA, USA. .

Pokaż więcej

Źródło:

Diagnostic pathology [Diagn Pathol] 2022 Aug 05; Vol. 17 (1), pp. 63. Date of Electronic Publication: 2022 Aug 05.

Typ publikacji:

Case Reports; Journal Article; Review

MeSH Terms:

Heavy Chain Disease*
Leukemia, Lymphocytic, Chronic, B-Cell*/diagnosis
Leukemia, Lymphocytic, Chronic, B-Cell*/genetics
Lymphocytosis*
Lymphoma*
Waldenstrom Macroglobulinemia*/diagnosis
Waldenstrom Macroglobulinemia*/genetics
Waldenstrom Macroglobulinemia*/pathology
Humans ; Mutation ; Myeloid Differentiation Factor 88/genetics

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 21.

Tytuł:

Bing-Neel syndrome coexisting with oligodendroglioma.

Autorzy:

Donzelli L; Hematology Unit, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
Minotti C; Hematology Unit, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
Torelli GF; Hematology Unit, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
Cartoni C; Hematology Unit, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
Luise C; Hematology Unit, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
Di Rocco A; Hematology Unit, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
Petrucci L; Hematology Unit, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
Di Napoli A; Pathology Unit, Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Sapienza University, Rome, Italy.
Martelli M; Hematology Unit, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.

Pokaż więcej

Źródło:

Leukemia & lymphoma [Leuk Lymphoma] 2022 Oct; Vol. 63 (10), pp. 2511-2514. Date of Electronic Publication: 2022 May 19.

Typ publikacji:

Letter

MeSH Terms:

Brain Diseases*
Oligodendroglioma*/complications
Oligodendroglioma*/diagnosis
Waldenstrom Macroglobulinemia*/complications
Humans ; Magnetic Resonance Imaging

Opinia redakcyjna

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 22.

Tytuł:

Clinicoradiopathological correlation of symptomatic focal bone marrow lesions in Waldenström Macroglobulinaemia.

Autorzy:

Arulogun SO; Clinical Haematology, Cancer Division, University College London Hospital, London, UK.
Abbasi MA; Department of Radiology, University College London Hospital, London, UK.
Pomplun S; Department of Histopathology, University College London Hospital, London, UK.
O'Neill AT; Clinical Haematology, Cancer Division, University College London Hospital, London, UK.
Wan S; Department of Nuclear Medicine, University College London Hospital, London, UK.
Wechalekar A; Clinical Haematology, Cancer Division, University College London Hospital, London, UK.; Division of Medicine, University College London, London, UK.
D'Sa SP; Clinical Haematology, Cancer Division, University College London Hospital, London, UK.; Cancer Institute, University College London, London, UK.

Pokaż więcej

Źródło:

Leukemia & lymphoma [Leuk Lymphoma] 2022 Jun; Vol. 63 (6), pp. 1496-1499. Date of Electronic Publication: 2022 Jan 22.

Typ publikacji:

Letter

MeSH Terms:

Bone Diseases*/pathology
Lymphoma, B-Cell*/pathology
Waldenstrom Macroglobulinemia*/diagnosis
Waldenstrom Macroglobulinemia*/pathology
Bone Marrow/pathology ; Humans

Opinia redakcyjna

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 23.

Tytuł:

MYD88 Mutations: Transforming the Landscape of IgM Monoclonal Gammopathies.

Autorzy:

Alcoceba M; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain.
García-Álvarez M; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain.
Medina A; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain.
Maldonado R; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain.
González-Calle V; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain.
Chillón MC; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain.
Sarasquete ME; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain.
González M; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain.
García-Sanz R; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain.
Jiménez C; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain.

Pokaż więcej

Źródło:

International journal of molecular sciences [Int J Mol Sci] 2022 May 16; Vol. 23 (10). Date of Electronic Publication: 2022 May 16.

Typ publikacji:

Journal Article; Review

MeSH Terms:

Mutation*
Myeloid Differentiation Factor 88*/genetics
Myeloid Differentiation Factor 88*/metabolism
Waldenstrom Macroglobulinemia*/diagnosis
Waldenstrom Macroglobulinemia*/genetics
Waldenstrom Macroglobulinemia*/metabolism
Aged ; Humans ; Immunoglobulin M/genetics ; Immunoglobulin M/metabolism ; Lymphoma/genetics ; Lymphoma/metabolism ; Lymphoma, B-Cell/genetics ; Lymphoma, B-Cell/metabolism

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 24.

Tytuł:

Discriminating between Waldenström macroglobulinemia and marginal zone lymphoma using logistic LASSO regression.

Autorzy:

Amaador K; Department of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam and LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands.
Vos JMI; Department of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam and LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands.
Pals ST; Department of Pathology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam and LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands.
Kraan W; Department of Pathology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam and LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands.
Dobber JA; Laboratory of Hematology, Amsterdam UMC, Amsterdam, The Netherlands.
Minnema MC; Department of Hematology, University Medical Center, University Utrecht, Utrecht, The Netherlands.
Koene HR; Department of Internal Medicine, St. Antonius Hospital, Nieuwegein, The Netherlands.
de Bruin PC; Department of Pathology, St. Antonius Hospital, Nieuwegein, The Netherlands.
Zwinderman AH; Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam UMC, University of Amsterdam, The Netherlands.
Kersten MJ; Department of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam and LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands.

Pokaż więcej

Źródło:

Leukemia & lymphoma [Leuk Lymphoma] 2022 May; Vol. 63 (5), pp. 1070-1079. Date of Electronic Publication: 2021 Dec 27.

Typ publikacji:

Journal Article

MeSH Terms:

Lymphoma, B-Cell, Marginal Zone*/pathology
Waldenstrom Macroglobulinemia*/diagnosis
Waldenstrom Macroglobulinemia*/genetics
Waldenstrom Macroglobulinemia*/pathology
Bone Marrow/pathology ; Humans ; Immunophenotyping ; Mutation ; Myeloid Differentiation Factor 88/genetics

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 25.

Tytuł:

Concurrent Waldenstrom's Macroglobulinemia and Myelodysplastic Syndrome with a Sequent t(10;13)(p13;q22) Translocation.

Autorzy:

DeRosa PA; Department of Pathology, University of Maryland Medical System, Baltimore, MD 21201, USA.
Roche KC; Department of Medicine, The George Washington University, Washington, DC 20037, USA.
Nava VE; Department of Pathology, The George Washington University, Washington, DC 20037, USA.; Department of Pathology, Veterans Health Administration Medical Center, Washington, DC 20422, USA.
Singh S; Quest Diagnostics, Chantilly, VA 20151, USA.
Liu ML; Department of Pathology, The George Washington University, Washington, DC 20037, USA.; Department of Pathology, Veterans Health Administration Medical Center, Washington, DC 20422, USA.
Agarwal A; Department of Hematology and Oncology, The George Washington University, Washington, DC 20037, USA.; Department of Hematology and Oncology, Veterans Health Administration Medical Center, Washington, DC 20422, USA.

Pokaż więcej

Źródło:

Current oncology (Toronto, Ont.) [Curr Oncol] 2022 Jun 29; Vol. 29 (7), pp. 4587-4592. Date of Electronic Publication: 2022 Jun 29.

Typ publikacji:

Case Reports

MeSH Terms:

Lymphoma*
Myelodysplastic Syndromes*/genetics
Waldenstrom Macroglobulinemia*/genetics
Humans ; Immunoglobulin M/genetics ; Myeloid Differentiation Factor 88/genetics ; Translocation, Genetic

Raport

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 26.

Tytuł:

T-cell subset composition and functionality in patients with Waldenström's macroglobulinemia.

Autorzy:

Amaador K; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Martens A; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, Amsterdam, The Netherlands.
de Boer R; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, Amsterdam, The Netherlands.
Rietveld J; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, Amsterdam, The Netherlands.
Heemskerk M; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
Rutten CE; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Eldering E; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Amsterdam, The Netherlands.
Kersten MJ; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Amsterdam, The Netherlands.
Kater AP; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Amsterdam, The Netherlands.
Vos J; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Amsterdam, The Netherlands.
Tonino S; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Amsterdam, The Netherlands.

Pokaż więcej

Źródło:

Leukemia & lymphoma [Leuk Lymphoma] 2022 Jun; Vol. 63 (6), pp. 1469-1473. Date of Electronic Publication: 2022 Feb 01.

Typ publikacji:

Letter

MeSH Terms:

Waldenstrom Macroglobulinemia*/diagnosis
Humans ; Mutation ; Myeloid Differentiation Factor 88/genetics ; T-Lymphocyte Subsets

Opinia redakcyjna

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 27.

Tytuł:

A phase-II study of atezolizumab in combination with obinutuzumab or rituximab for relapsed or refractory mantle cell or marginal zone lymphoma or Waldenström's macroglobulinemia.

Autorzy:

Panayiotidis P; Laikon General Hospital and National and Kapodistrian University of Athens, Athens, Greece.
Tumyan G; N.N. Blokhin Russian Cancer Research Centre, Moscow, Russian Federation.
Thieblemont C; AP-HP, Hôpital Saint-Louis, and Université de Paris, Paris, France.
Ptushkin VV; City Clinical Hospital Named After S.P. Botkin, Moscow, Russian Federation.
Marin-Niebla A; Hospital Universitari Vall d'Hebron, Barcelona, Spain.
García-Sanz R; Hospital Universitario de Salamanca (HUSA/IBSAL/CIBERONC), Salamanca, Spain.
Le Gouill S; Service d'Hématologie Clinique du CHU de Nantes, INSERM CRCINA Nantes-Angers, NeXT Université de Nantes, Nantes, France.
Stathis A; Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland, and Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland.
Bottos A; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Hamidi H; Genentech, Inc, South San Francisco, CA, USA.
Katz P; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Perretti T; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Willis JC; Roche Products Ltd, Welwyn Garden City, UK.
Buske C; CCC Ulm, Institute of Experimental Cancer Research, University Hospital Ulm, Ulm, Germany.

Pokaż więcej

Źródło:

Leukemia & lymphoma [Leuk Lymphoma] 2022 May; Vol. 63 (5), pp. 1058-1069. Date of Electronic Publication: 2022 Jan 19.

Typ publikacji:

Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

MeSH Terms:

Antineoplastic Combined Chemotherapy Protocols*/adverse effects
Lymphoma, B-Cell, Marginal Zone*/drug therapy
Waldenstrom Macroglobulinemia*/drug therapy
Adult ; Antibodies, Monoclonal, Humanized ; Humans ; Rituximab/therapeutic use

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 28.

Tytuł:

Plamotamab (XmAb 13676) for Ibrutinib- refractory CXCR4-mutated extramedullary Waldenström macroglobulinemia.

Autorzy:

Parrondo RD; Deparment of Hematology-Oncology, Mayo Clinic Florida, Jacksonville, FL, USA.
Paulus A; Deparment of Hematology-Oncology, Mayo Clinic Florida, Jacksonville, FL, USA.
Alegria V; Deparment of Hematology-Oncology, Mayo Clinic Florida, Jacksonville, FL, USA.
Liebowitz D; Xencor, Inc, Monrovia, CA, USA.
Johnson C; Xencor, Inc, Monrovia, CA, USA.
Clynes R; Xencor, Inc, Monrovia, CA, USA.
Roy V; Deparment of Hematology-Oncology, Mayo Clinic Florida, Jacksonville, FL, USA.
Menke DM; Department of Pathology, Mayo Clinic Florida, Jacksonville, FL, USA.
Jiang L; Department of Pathology, Mayo Clinic Florida, Jacksonville, FL, USA.
Chanan-Khan AA; Deparment of Hematology-Oncology, Mayo Clinic Florida, Jacksonville, FL, USA.
Ailawadhi S; Deparment of Hematology-Oncology, Mayo Clinic Florida, Jacksonville, FL, USA.

Pokaż więcej

Źródło:

Leukemia & lymphoma [Leuk Lymphoma] 2022 Mar; Vol. 63 (3), pp. 738-742. Date of Electronic Publication: 2021 Nov 16.

Typ publikacji:

Letter; Research Support, Non-U.S. Gov't

MeSH Terms:

Waldenstrom Macroglobulinemia*/diagnosis
Waldenstrom Macroglobulinemia*/drug therapy
Waldenstrom Macroglobulinemia*/genetics
Adenine/analogs & derivatives ; Humans ; Myeloid Differentiation Factor 88/genetics ; Piperidines ; Receptors, CXCR4/genetics

Raport

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 29.

Tytuł:

Bortezomib provides favorable efficacy in type 3 acquired von willebrand syndrome related to lymphoplasmacytic lymphoma/Waldenstrom's macroglobulinemia.

Autorzy:

Kong D; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Suzhou University, Suzhou, China.; Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China.
Li Y; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Suzhou University, Suzhou, China.; Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China.
Fu C; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Suzhou University, Suzhou, China.; Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China.
Hou M; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Soochow Hopes Hematology Hospital, Suzhou, China.
Yan L; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Suzhou University, Suzhou, China.; Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China.
Shang J; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Suzhou University, Suzhou, China.; Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China.
Wang Z; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Suzhou University, Suzhou, China.; Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China.
Yin J; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Suzhou University, Suzhou, China.; Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China.
Yu Z; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Suzhou University, Suzhou, China.; Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China.
Wu D; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Suzhou University, Suzhou, China.; Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China.

Pokaż więcej

Źródło:

Leukemia & lymphoma [Leuk Lymphoma] 2022 Feb; Vol. 63 (2), pp. 491-494. Date of Electronic Publication: 2021 Oct 20.

Typ publikacji:

Letter; Research Support, Non-U.S. Gov't

MeSH Terms:

Lymphoma, B-Cell*
Waldenstrom Macroglobulinemia*/complications
Waldenstrom Macroglobulinemia*/diagnosis
Waldenstrom Macroglobulinemia*/drug therapy
von Willebrand Diseases*/diagnosis
von Willebrand Diseases*/drug therapy
von Willebrand Diseases*/etiology
Bortezomib/therapeutic use ; Humans

Raport

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 30.

Tytuł:

Waldenström macroglobulinemia and relationship to immune deficiency.

Autorzy:

Levy A; Service d'Hématologie et Thérapie Cellulaire, CHU and Inserm, Poitiers, France.
Guidez S; Service d'Hématologie et Thérapie Cellulaire, CHU and Inserm, Poitiers, France.
Debiais C; Laboratoire d'Anatomie Pathologie, CHU, Poitiers, France.
Princet I; Pharmacie Centrale, CHU, Poitiers, France.
Bouyer S; Service d'Hématologie Biologique, CHU, Poitiers, France.
Dindinaud E; Service d'Hématologie Biologique, CHU, Poitiers, France.
Delwail V; Service d'Hématologie et Thérapie Cellulaire, CHU and Inserm, Poitiers, France.
Systchenko T; Service d'Hématologie et Thérapie Cellulaire, CHU and Inserm, Poitiers, France.
Moya N; Service d'Hématologie et Thérapie Cellulaire, CHU and Inserm, Poitiers, France.
Gruchet C; Service d'Hématologie et Thérapie Cellulaire, CHU and Inserm, Poitiers, France.
Sabirou F; Service d'Hématologie et Thérapie Cellulaire, CHU and Inserm, Poitiers, France.
Bobin A; Service d'Hématologie et Thérapie Cellulaire, CHU and Inserm, Poitiers, France.
Gardeney H; Service d'Hématologie et Thérapie Cellulaire, CHU and Inserm, Poitiers, France.
Nsiala L; Service d'Hématologie et Thérapie Cellulaire, CHU and Inserm, Poitiers, France.
Cailly L; Service d'Hématologie et Thérapie Cellulaire, CHU and Inserm, Poitiers, France.
Olivier G; Service de Médecine Interne, Niort, France.
Motard C; Service de Médecine Interne, Niort, France.
Fleck E; Service d'Onco-Hématologie, La Rochelle, France.
Corby A; Service d'Onco-Hématologie, La Rochelle, France.
Roul C; Service d'Onco-Hématologie, La Rochelle, France.
Denis G; Service de Médecine Interne, Rochefort, France.
Dieval C; Service de Médecine Interne, Rochefort, France.
Leleu X; Service d'Hématologie et Thérapie Cellulaire, CHU and Inserm, Poitiers, France.
Tomowiak C; Service d'Hématologie et Thérapie Cellulaire, CHU and Inserm, Poitiers, France.

Pokaż więcej

Źródło:

Leukemia & lymphoma [Leuk Lymphoma] 2021 Nov; Vol. 62 (11), pp. 2665-2670. Date of Electronic Publication: 2021 Jun 04.

Typ publikacji:

Journal Article; Review

MeSH Terms:

Immunologic Deficiency Syndromes*
Lymphoma, B-Cell*
Waldenstrom Macroglobulinemia*/diagnosis
Waldenstrom Macroglobulinemia*/epidemiology
Humans ; Incidence

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 31.

Tytuł:

Treatment and outcome patterns of patients with Waldenström's macroglobulinemia: a large, multicenter retrospective review in China.

Autorzy:

Cao XX; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Yi SH; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Blood Diseases Hospital & Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
Jiang ZX; Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Henan, China.
He JS; Department of Hematology, Bone Marrow Transplantation Center, The First Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang, China.
Yang W; Department of Hematology, Shengjing Hospital of China Medical University, Liaoning, China.
Du J; Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, The Second Military Medical University, Shanghai, China.
Sun CY; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, China.
Wu Y; Department of Hematology, West China Hospital of Sichuan University, Sichuan, China.
Chen WM; Department of Hematology, Beijing Chao-Yang Hospital of Capital Medical University, Beijing, China.
Liu XJ; Department of Hematology, The Second Hospital of Hebei Medical University, Hebei, China.
Li BZ; Department of Hematology, The Second Affiliated Hospital of Soochow University, Jiangsu, China.
Li CR; Department of Hematology, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Hubei, China.
Sang W; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Jiangsu, China.
Liu QH; Department of Hematology, The First Affiliated Hospital of Anhui Medical University, Anhui, China.
Chu XX; Department of Hematology, Yuhuangding Hospital of Yantai, Shandong, China.
Li F; Department of Hematology, The First Affiliated Hospital of Nanchang University, Jiangxi, China.
Bai O; Department of Hematology, The First Affiliated Hospital of Jilin University, Jilin, China.
Mao M; Department of Hematology, Xinjiang Uyghur Municipal People's Hospital, Xinjiang, China.
Fu R; Department of Hematology, Tianjin Medical University General Hospital, Tianjin, China.
Wang W; Department of Hematology, The Affiliated Hospital of Qingdao University, Shandong, China.
Liu LH; Department of Hematology, The fourth Hospital of Hebei Medical University, Hebei, China.
Wang LQ; Department of Hematology, Qilu Hospital of Shandong University, Shandong, China.
Dong YJ; Department of Hematology, Peking University First Hospital, Beijing, China.
Luo J; Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Guangxi, China.
Li ZL; Department of Hematology, China-Japan Friendship Hospital, Beijing China.
Wei YQ; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangdong, China.
Zhang QK; Department of Hematology, Gansu Provincial Hospital, Gansu, China.
Liu J; Department of Hematology, The Third Xiangya Hospital of Central South University, Hunan, China.
Ding KY; Department of Hematology, The First Affiliated Hospital of University of Science and Technology of China, Anhui, China.
Zou L; Department of Hematology, Hubei, China.
Chen BY; Department of Hematology, Fujian Provincial Hospital, Fujian, China.
Hua LM; Department of Hematology, The Affiliated Hospital of Hebei University, Hebei, China.
Jing HM; Department of Hematology, Peking University Third Hospital, Beijing, China.
He J; Department of Hematology, The First Hospital of China Medical University, Liaoning, China.
Wang L; Department of Hematology, Zhujiang Hospital of Southern Medical University, Guangdong, China.
Li J; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Qiu LG; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Blood Diseases Hospital & Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.

Pokaż więcej

Źródło:

Leukemia & lymphoma [Leuk Lymphoma] 2021 Nov; Vol. 62 (11), pp. 2657-2664. Date of Electronic Publication: 2021 Jun 09.

Typ publikacji:

Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

MeSH Terms:

Waldenstrom Macroglobulinemia*/diagnosis
Waldenstrom Macroglobulinemia*/drug therapy
Waldenstrom Macroglobulinemia*/epidemiology
Aged ; Humans ; Prognosis ; Retrospective Studies ; Rituximab ; Treatment Outcome

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 32.

Tytuł:

Meningeal Involvement as Initial Presentation of Waldenström Macroglobulinemia (Bing-Neel Syndrome).

Autorzy:

Pappolla A; Department of Neurology, Italian Hospital of Buenos Aires, Buenos Aires, Argentina.
Cristina ZM; Department of Neurology, Italian Hospital of Buenos Aires, Buenos Aires, Argentina.
Rugiero M; Department of Neurology, Italian Hospital of Buenos Aires, Buenos Aires, Argentina.
Christiansen S; Department of Pathology, Italian Hospital of Buenos Aires, Buenos Aires, Argentina.
Rivello HG; Department of Pathology, Italian Hospital of Buenos Aires, Buenos Aires, Argentina.

Pokaż więcej

Źródło:

Neurology India [Neurol India] 2021 Sep-Oct; Vol. 69 (5), pp. 1459-1460.

Typ publikacji:

Letter

MeSH Terms:

Brain Diseases*
Neurodegenerative Diseases*
Waldenstrom Macroglobulinemia*/complications
Waldenstrom Macroglobulinemia*/diagnosis
Humans ; Magnetic Resonance Imaging ; Meninges

Opinia redakcyjna

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 33.

Tytuł:

Clinical application of genomics in Waldenström macroglobulinemia.

Autorzy:

Branagan AR; Department of Hematologic Oncology, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Lei M; Department of Pharmacy, Massachusetts General Hospital, Boston, MA, USA.
Treon SP; Harvard Medical School, Boston, MA, USA.; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.
Castillo JJ; Harvard Medical School, Boston, MA, USA.; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.

Pokaż więcej

Źródło:

Leukemia & lymphoma [Leuk Lymphoma] 2021 Aug; Vol. 62 (8), pp. 1805-1815. Date of Electronic Publication: 2021 Feb 11.

Typ publikacji:

Journal Article; Review

MeSH Terms:

Waldenstrom Macroglobulinemia*/diagnosis
Waldenstrom Macroglobulinemia*/drug therapy
Waldenstrom Macroglobulinemia*/genetics
Genomics ; Humans ; Mutation ; Myeloid Differentiation Factor 88/genetics ; Protein Kinase Inhibitors

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 34.

Tytuł:

Blistering lesions associated with Waldenström macroglobulinemia: New insights into pathogenesis.

Autorzy:

Garcovich S; Institute of Dermatology, Università Cattolica del Sacro Cuore, Rome, Italy.; Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Rome, Italy.
Didona D; Department of Dermatology and Allergology, Philipps University, Marburg, Germany.
De Simone C; Institute of Dermatology, Università Cattolica del Sacro Cuore, Rome, Italy.; Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Rome, Italy.
De Stefano V; Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Rome, Italy.; Institute of Hematology, Università Cattolica del Sacro Cuore, Rome, Italy.
Mariotti F; IDI-IRCCS, Rome, Italy.
Di Zenzo G; IDI-IRCCS, Rome, Italy.

Pokaż więcej

Źródło:

Dermatologic therapy [Dermatol Ther] 2021 Sep; Vol. 34 (5), pp. e15072. Date of Electronic Publication: 2021 Aug 10.

Typ publikacji:

Letter

MeSH Terms:

Waldenstrom Macroglobulinemia*/diagnosis
Humans ; Mutation

Opinia redakcyjna

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 35.

Tytuł:

Clinical Relevance of the High Prevalence of MYD88 L265P Mutated Vitreoretinal Lymphoma Identified by Droplet Digital Polymerase Chain Reaction.

Autorzy:

Shi H; Department of Ophthalmology, North Huashan Hospital, Fudan University, Shanghai, China.
Zhou X; Department of Ophthalmology, Huashan Hospital, Fudan University, Shanghai, China.
Chen B; Department of Hematology, Huashan Hospital, Fudan University, Shanghai, China.
Xiao J; Department of Ophthalmology, North Huashan Hospital, Fudan University, Shanghai, China.
Li Y; Department of Ophthalmology, North Huashan Hospital, Fudan University, Shanghai, China.
Zhou X; Department of Ophthalmology, Huashan Hospital, Fudan University, Shanghai, China.
Zhou Q; Department of Ophthalmology, North Huashan Hospital, Fudan University, Shanghai, China.
Chen K; Department of Laboratory Medicine, North Huashan Hospital, Fudan University, Shanghai, China.
Wang Q; Department of Ophthalmology, Huashan Hospital, Fudan University, Shanghai, China.

Pokaż więcej

Źródło:

Ocular immunology and inflammation [Ocul Immunol Inflamm] 2021 Apr 03; Vol. 29 (3), pp. 448-455. Date of Electronic Publication: 2019 Oct 11.

Typ publikacji:

Journal Article

MeSH Terms:

Mutation, Missense*
Intraocular Lymphoma/*genetics
Lymphoma, Large B-Cell, Diffuse/*genetics
Myeloid Differentiation Factor 88/*genetics
Retinal Neoplasms/*genetics
Vitreous Body/*pathology
Waldenstrom Macroglobulinemia/*genetics
Adult ; Aged ; Female ; Humans ; Immunohistochemistry ; Intraocular Lymphoma/diagnostic imaging ; Intraocular Lymphoma/pathology ; Leucine/genetics ; Lymphoma, Large B-Cell, Diffuse/diagnostic imaging ; Lymphoma, Large B-Cell, Diffuse/pathology ; Male ; Middle Aged ; Polymerase Chain Reaction ; Proline/genetics ; Prospective Studies ; Retinal Neoplasms/pathology ; Vitrectomy ; Waldenstrom Macroglobulinemia/diagnostic imaging ; Waldenstrom Macroglobulinemia/pathology

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 36.

Tytuł:

A Promising New Therapy of Oral Ixazomib Without Rituximab for Waldenstrom Macroglobulinemia

Autorzy:

Ma W; Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Department of Endocrinology, Beijing, China
Zhao J; Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Department of Rheumatology, Beijing, China
Zhang L; Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Department of Hematology, Beijing, China

Pokaż więcej

Źródło:

Turkish journal of haematology : official journal of Turkish Society of Haematology [Turk J Haematol] 2021 Feb 25; Vol. 38 (1), pp. 87-89. Date of Electronic Publication: 2020 Oct 30.

Typ publikacji:

Case Reports; Letter

MeSH Terms:

Antineoplastic Agents/*administration & dosage
Boron Compounds/*administration & dosage
Glycine/*analogs & derivatives
Protease Inhibitors/*administration & dosage
Waldenstrom Macroglobulinemia/*drug therapy
Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Biomarkers ; Female ; Glycine/administration & dosage ; Humans ; Rituximab/administration & dosage ; Tomography, X-Ray Computed ; Treatment Outcome ; Waldenstrom Macroglobulinemia/diagnosis

Raport

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 37.

Tytuł:

Treatment facility volume and patient outcomes in Waldenstrom macroglobulinemia.

Autorzy:

Gunaratne MDSK; Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Sahakian AJ; Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Abeykoon JP; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Ansell SM; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Gertz MA; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Kapoor P; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Paulus A; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, USA.
Ailawadhi S; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, USA.
Reeder CB; Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ, USA.
Witzig TE; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Habermann TM; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Novak AJ; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Lacy MQ; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Kyle RA; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Go RS; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Paludo J; Division of Hematology, Mayo Clinic, Rochester, MN, USA.

Pokaż więcej

Źródło:

Leukemia & lymphoma [Leuk Lymphoma] 2021 Feb; Vol. 62 (2), pp. 308-315. Date of Electronic Publication: 2020 Oct 15.

Typ publikacji:

Journal Article

MeSH Terms:

Waldenstrom Macroglobulinemia*/diagnosis
Waldenstrom Macroglobulinemia*/epidemiology
Waldenstrom Macroglobulinemia*/therapy
Databases, Factual ; Humans ; Incidence ; Risk Factors

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 38.

Tytuł:

Systemic mastocytosis and lymphoplasmacytic lymphoma: an unusual and intriguing form of SM-AHN.

Autorzy:

Bonometti A; Unit of Anatomic Pathology, Department of Molecular Medicine, IRCCS San Matteo Foundation, University of Pavia, Pavia, Italy.
Boveri E; Unit of Anatomic Pathology, IRCCS San Matteo Foundation, Pavia, Italy.
Varettoni M; Unit of Hematology, IRCCS San Matteo Foundation, University of Pavia, Pavia, Italy.
Ripamonti A; Unit of Anatomic Pathology, Department of Molecular Medicine, IRCCS San Matteo Foundation, University of Pavia, Pavia, Italy.
Fraticelli S; Unit of Anatomic Pathology, Department of Molecular Medicine, IRCCS San Matteo Foundation, University of Pavia, Pavia, Italy.
Lucioni M; Unit of Anatomic Pathology, IRCCS San Matteo Foundation, Pavia, Italy.
Zibellini S; Unit of Hematology, IRCCS San Matteo Foundation, University of Pavia, Pavia, Italy.
Elena C; Unit of Hematology, IRCCS San Matteo Foundation, University of Pavia, Pavia, Italy.
Pietra D; Unit of Hematology, IRCCS San Matteo Foundation, University of Pavia, Pavia, Italy.
Arcaini L; Unit of Hematology, IRCCS San Matteo Foundation, University of Pavia, Pavia, Italy.
Paulli M; Unit of Anatomic Pathology, Department of Molecular Medicine, IRCCS San Matteo Foundation, University of Pavia, Pavia, Italy.

Pokaż więcej

Źródło:

Leukemia & lymphoma [Leuk Lymphoma] 2021 Jul; Vol. 62 (7), pp. 1782-1785. Date of Electronic Publication: 2021 Feb 14.

Typ publikacji:

Letter

MeSH Terms:

Lymphoma, B-Cell*
Mast-Cell Sarcoma*
Mastocytosis, Systemic*/diagnosis
Mastocytosis, Systemic*/genetics
Myelodysplastic-Myeloproliferative Diseases*
Waldenstrom Macroglobulinemia*/diagnosis
Humans

Opinia redakcyjna

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 39.

Tytuł:

Population Pharmacokinetic Analysis of the BTK Inhibitor Zanubrutinib in Healthy Volunteers and Patients With B-Cell Malignancies.

Autorzy:

Ou YC; BeiGene USA, Inc., San Mateo, California, USA.
Liu L; Shanghai Qiangshi Information Technology Co., Ltd, Shanghai, China.
Tariq B; BeiGene USA, Inc., San Mateo, California, USA.
Wang K; Shanghai Qiangshi Information Technology Co., Ltd, Shanghai, China.
Jindal A; BeiGene USA, Inc., San Mateo, California, USA.
Tang Z; BeiGene USA, Inc., San Mateo, California, USA.
Gao Y; Shanghai Qiangshi Information Technology Co., Ltd, Shanghai, China.
Sahasranaman S; BeiGene USA, Inc., San Mateo, California, USA.

Pokaż więcej

Źródło:

Clinical and translational science [Clin Transl Sci] 2021 Mar; Vol. 14 (2), pp. 764-772. Date of Electronic Publication: 2021 Jan 25.

Typ publikacji:

Journal Article; Research Support, Non-U.S. Gov't

MeSH Terms:

Leukemia, B-Cell/*drug therapy
Lymphoma, B-Cell/*drug therapy
Piperidines/*pharmacokinetics
Protein Kinase Inhibitors/*pharmacokinetics
Pyrazoles/*pharmacokinetics
Pyrimidines/*pharmacokinetics
Waldenstrom Macroglobulinemia/*drug therapy
Adult ; Aged ; Aged, 80 and over ; Biological Variation, Population ; Case-Control Studies ; Clinical Trials as Topic ; Dose-Response Relationship, Drug ; Female ; Healthy Volunteers ; Humans ; Leukemia, B-Cell/blood ; Lymphoma, B-Cell/blood ; Male ; Middle Aged ; Models, Biological ; Piperidines/administration & dosage ; Protein Kinase Inhibitors/administration & dosage ; Pyrazoles/administration & dosage ; Pyrimidines/administration & dosage ; Waldenstrom Macroglobulinemia/blood ; Young Adult

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 40.

Tytuł:

Novel tumor-targeted liposomes comprised of an MDM2 antagonist plus proteasome inhibitor display anti-tumor activity in a xenograft model of bortezomib-resistant Waldenstrom macroglobulinemia.

Autorzy:

Madamsetty VS; Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine and Science, Jacksonville, FL, USA.
Paulus A; Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, USA.
Akhtar S; Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, USA.
Manna A; Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, USA.
Rachamalla HR; Department of Applied Biology, CSIR-Indian Institute of Chemical Technology, Hyderabad, India.; Academy of Scientific and Innovative Research (AcSIR, CSIR - Human Resource Development Centre, (CSIR-HRDC) Campus, Ghaziabad, India.
Banerjee R; Department of Applied Biology, CSIR-Indian Institute of Chemical Technology, Hyderabad, India.; Academy of Scientific and Innovative Research (AcSIR, CSIR - Human Resource Development Centre, (CSIR-HRDC) Campus, Ghaziabad, India.
Mukhopadhyay D; Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine and Science, Jacksonville, FL, USA.
Chanan-Khan A; Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine and Science, Jacksonville, FL, USA.; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, USA.; Mayo Clinic Cancer Center at St. Vincent's Medical Center Riverside, Jacksonville, FL, USA.

Pokaż więcej

Źródło:

Leukemia & lymphoma [Leuk Lymphoma] 2020 Oct; Vol. 61 (10), pp. 2399-2408. Date of Electronic Publication: 2020 Jun 19.

Typ publikacji:

Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

MeSH Terms:

Proteasome Inhibitors*/pharmacology
Waldenstrom Macroglobulinemia*
Animals ; Bortezomib/pharmacology ; Heterografts ; Liposomes ; Mice ; Proteasome Endopeptidase Complex ; Tissue Distribution

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 41.

Tytuł:

Ibrutinib does not have clinically relevant interactions with oral contraceptives or substrates of CYP3A and CYP2B6.

Autorzy:

de Jong J; Clinical Pharmacology, Janssen Research & Development LLC, San Diego, CA, USA.
Mitselos A; Clinical Research Oncology, Janssen Research & Development LLC, Beerse, Belgium.
Jurczak W; Maria Sklodowska-Curie National Institute of Oncology, Krakow, Poland.
Cordoba R; Lymphoma Unit, Department of Hematology, Fundacion Jimenez Diaz University Hospital, Madrid, Spain.; Health Research Institute IIS-FJD, Madrid, Spain.; START Madrid, Phase 1 Clinical Trials Unit, Madrid, Spain.
Panizo C; Department of Hematology, Clínica Universidad de Navarra, Pamplona, Spain.; Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain.
Wrobel T; Department and Clinic of Hematology, Blood Neoplasms, and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland.
Dlugosz-Danecka M; Maria Sklodowska-Curie National Institute of Oncology, Krakow, Poland.
Jiao J; Clinical Pharmacology, Janssen Research & Development LLC, Raritan, NJ, USA.
Sukbuntherng J; Pharmacyclics LLC, an AbbVie company, Sunnyvale, CA, USA.
Ouellet D; Clinical Pharmacology, Janssen Research & Development LLC, Spring House, PA, USA.
Hellemans P; Clinical Research Oncology, Janssen Research & Development LLC, Beerse, Belgium.

Pokaż więcej

Źródło:

Pharmacology research & perspectives [Pharmacol Res Perspect] 2020 Oct; Vol. 8 (5), pp. e00649.

Typ publikacji:

Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

MeSH Terms:

Adenine/*analogs & derivatives
Contraceptives, Oral/*administration & dosage
Cytochrome P-450 CYP2B6/*metabolism
Cytochrome P-450 CYP3A/*metabolism
Leukemia, Lymphocytic, Chronic, B-Cell/*drug therapy
Lymphoma, B-Cell, Marginal Zone/*drug therapy
Lymphoma, Mantle-Cell/*drug therapy
Piperidines/*administration & dosage
Waldenstrom Macroglobulinemia/*drug therapy
Adenine/administration & dosage ; Administration, Oral ; Adult ; Aged ; Aged, 80 and over ; Area Under Curve ; Bupropion/administration & dosage ; Bupropion/pharmacokinetics ; Contraceptives, Oral/pharmacokinetics ; Drug Interactions ; Ethinyl Estradiol/administration & dosage ; Ethinyl Estradiol/pharmacokinetics ; Female ; Humans ; Leukemia, Lymphocytic, Chronic, B-Cell/blood ; Leukemia, Lymphocytic, Chronic, B-Cell/metabolism ; Levonorgestrel/administration & dosage ; Levonorgestrel/pharmacokinetics ; Lymphoma, B-Cell, Marginal Zone/blood ; Lymphoma, B-Cell, Marginal Zone/metabolism ; Lymphoma, Mantle-Cell/blood ; Lymphoma, Mantle-Cell/metabolism ; Metabolic Clearance Rate ; Midazolam/administration & dosage ; Midazolam/pharmacokinetics ; Middle Aged ; Waldenstrom Macroglobulinemia/blood ; Waldenstrom Macroglobulinemia/metabolism

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 42.

Tytuł:

An unusual case of cutaneous Waldenström macroglobulinemia with the MYD88 L265P mutation.

Autorzy:

Minzenmayer AN; Department of Dermatology, Baylor Scott and White Central Texas, Temple, Texas, USA.
Miranda RN; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Powell PR; Department of Pathology, Baylor Scott and White Central Texas, Temple, Texas, USA.
Parekh PK; Department of Dermatology, Baylor Scott and White Central Texas, Temple, Texas, USA.

Pokaż więcej

Źródło:

Journal of cutaneous pathology [J Cutan Pathol] 2020 Sep; Vol. 47 (9), pp. 850-853. Date of Electronic Publication: 2020 Jul 17.

Typ publikacji:

Case Reports

MeSH Terms:

Myeloid Differentiation Factor 88/*genetics
Skin Diseases/*metabolism
Waldenstrom Macroglobulinemia/*genetics
Aged ; Antineoplastic Agents, Alkylating/therapeutic use ; Antineoplastic Agents, Immunological/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Bendamustine Hydrochloride/therapeutic use ; Bone Marrow/metabolism ; Cell Differentiation ; Diagnosis, Differential ; Female ; Humans ; Immunoglobulin M/blood ; Immunoglobulin kappa-Chains/blood ; Lymphocytes/metabolism ; Lymphocytes/pathology ; Lymphoma, B-Cell, Marginal Zone/diagnosis ; Lymphoma, B-Cell, Marginal Zone/pathology ; Mutation ; Plasma Cells/metabolism ; Plasma Cells/pathology ; Rituximab/therapeutic use ; Skin Diseases/pathology ; Treatment Outcome ; Waldenstrom Macroglobulinemia/diagnosis ; Waldenstrom Macroglobulinemia/drug therapy ; Waldenstrom Macroglobulinemia/pathology

Raport

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 43.

Tytuł:

Cutaneous Involvement in Waldenström's Macroglobulinaemia.

Autorzy:

Stien S; Department of Oncodermatology, Robert Debré Hospital, avenue du Général Koenig, FR-51092 Reims Cedex, France. E-mail: .
Durot E
Durlach A
Beylot-Barry M
Adamski H
Beltraminelli H
Bohelay G
Carlotti A
Carpentier O
Cornillet P
Dubois R
Franck N
Husson B
Laroche L
Maubec E
le Clech C
Machet L
Ortonne N
Ram-Wolff C
Vergier B
Grange F

Pokaż więcej

Źródło:

Acta dermato-venereologica [Acta Derm Venereol] 2020 Aug 17; Vol. 100 (15), pp. adv00225. Date of Electronic Publication: 2020 Aug 17.

Typ publikacji:

Journal Article

MeSH Terms:

Waldenstrom Macroglobulinemia*/diagnosis
Waldenstrom Macroglobulinemia*/genetics
Humans ; Mutation ; Myeloid Differentiation Factor 88/genetics ; Retrospective Studies ; Skin

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 44.

Tytuł:

Predictors of short-term survival in Waldenström Macroglobulinemia.

Autorzy:

Ruan G; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Zanwar S; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Abeykoon JP; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Ansell SM; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Gertz M; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Go RS; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Muchtar E; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Gonsalves WI; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Paludo J; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Thanarajasingam G; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Inwards DJ; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Thompson CA; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Habermann TM; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Lin Y; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Nowakowski GS; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Bisneto JCV; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Dispenzieri A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Lacy MQ; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Buadi FK; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Dingli D; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Kourelis T; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Warsame R; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Rajkumar SV; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Kumar S; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Kapoor P; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.

Pokaż więcej

Źródło:

Leukemia & lymphoma [Leuk Lymphoma] 2020 Dec; Vol. 61 (12), pp. 2975-2979. Date of Electronic Publication: 2020 Jul 14.

Typ publikacji:

Letter

MeSH Terms:

Waldenstrom Macroglobulinemia*/diagnosis
Humans ; Mutation

Opinia redakcyjna

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 45.

Tytuł:

Pleural fluid MYD88 L265P mutation supporting diagnosis and decision to treat extramedullary Waldenstrom's macroglobulinemia: a case report.

Autorzy:

Barnes M; Department of Internal Medicine, Mather Hospital/Northwell Health, 75 North Country Rd, Port Jefferson, NY, 11777, USA. .
Sharma P; Department of Internal Medicine, Mather Hospital/Northwell Health, 75 North Country Rd, Port Jefferson, NY, 11777, USA.
Kumar V; Department of Internal Medicine, Mather Hospital/Northwell Health, 75 North Country Rd, Port Jefferson, NY, 11777, USA.
Kaell A; Department of Internal Medicine, Mather Hospital/Northwell Health, 75 North Country Rd, Port Jefferson, NY, 11777, USA.
LiPera W; New York Cancer & Blood Specialists, 49 Route 347, Port Jefferson Station, NY, 11776, USA.

Pokaż więcej

Źródło:

Journal of medical case reports [J Med Case Rep] 2020 Jul 13; Vol. 14 (1), pp. 98. Date of Electronic Publication: 2020 Jul 13.

Typ publikacji:

Case Reports; Journal Article

MeSH Terms:

Adenine/*analogs & derivatives
Myeloid Differentiation Factor 88/*genetics
Piperidines/*administration & dosage
Waldenstrom Macroglobulinemia/*drug therapy
Adenine/administration & dosage ; Adenine/adverse effects ; Aged ; Dose-Response Relationship, Drug ; Humans ; Male ; Mutation ; Piperidines/adverse effects ; Pleural Effusion, Malignant/diagnostic imaging ; Pleural Effusion, Malignant/pathology ; Remission Induction ; Tomography, X-Ray Computed ; Waldenstrom Macroglobulinemia/genetics ; Waldenstrom Macroglobulinemia/pathology

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 46.

Tytuł:

Composite monoclonal B-cell lymphocytosis and MYD88 L265P-positive lymphoplasmacytic lymphoma in a patient with IgM light chain amyloidosis: Case report.

Autorzy:

Oishi N; Department of Pathology, University of Yamanashi, Yamanashi, Japan.
Inoue T; Department of Pathology, University of Yamanashi, Yamanashi, Japan.
Odate T; Department of Pathology, University of Yamanashi, Yamanashi, Japan.
Mochizuki K; Department of Pathology, University of Yamanashi, Yamanashi, Japan.
Ohashi K; Department of Pathology, Yokohama City University, Kanagawa, Japan.
Kirito K; Department of Hematology, University of Yamanashi, Yamanashi, Japan.
Kondo T; Department of Pathology, University of Yamanashi, Yamanashi, Japan.

Pokaż więcej

Źródło:

Pathology international [Pathol Int] 2020 Jul; Vol. 70 (7), pp. 458-462. Date of Electronic Publication: 2020 Apr 22.

Typ publikacji:

Case Reports

MeSH Terms:

Amyloidosis/*complications
B-Lymphocytes/*pathology
Lymphocytosis/*complications
Precancerous Conditions/*complications
Waldenstrom Macroglobulinemia/*complications
Aged ; Amyloidosis/pathology ; Clone Cells/pathology ; Humans ; Lymphocytosis/pathology ; Male ; Myeloid Differentiation Factor 88/genetics ; Precancerous Conditions/pathology ; Waldenstrom Macroglobulinemia/genetics ; Waldenstrom Macroglobulinemia/pathology

Raport

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 47.

Tytuł:

A matched case-control study comparing features, treatment and outcomes between patients with non-IgM lymphoplasmacytic lymphoma and Waldenström macroglobulinemia.

Autorzy:

Castillo JJ; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.
Itchaki G; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel.
Gustine JN; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Boston University School of Medicine, Boston, MA, USA.
Meid K; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.
Flynn CA; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.
Demos MG; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.
Guerrera ML; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.
Jimenez C; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.
Kofides A; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.
Liu X; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.
Munshi M; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.
Tsakmaklis N; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.
Patterson CJ; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.
Xu L; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.
Yang G; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.
Hunter ZR; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.
Treon SP; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.

Pokaż więcej

Źródło:

Leukemia & lymphoma [Leuk Lymphoma] 2020 Jun; Vol. 61 (6), pp. 1388-1394. Date of Electronic Publication: 2020 Jan 29.

Typ publikacji:

Journal Article; Research Support, Non-U.S. Gov't

MeSH Terms:

Lymphoma, B-Cell*
Waldenstrom Macroglobulinemia*/diagnosis
Waldenstrom Macroglobulinemia*/drug therapy
Waldenstrom Macroglobulinemia*/epidemiology
Case-Control Studies ; Humans ; Mutation ; Treatment Outcome

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 48.

Tytuł:

Waldenstrom's macroglobulinemia in the era of immunotherapy.

Autorzy:

Vaxman I; Division of Hematology, Mayo Clinic, Rochester, MN, USA.; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah- Tikva, Israel.; Israel Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Gertz M; Division of Hematology, Mayo Clinic, Rochester, MN, USA.

Pokaż więcej

Źródło:

Leukemia & lymphoma [Leuk Lymphoma] 2020 Jun; Vol. 61 (6), pp. 1292-1304. Date of Electronic Publication: 2020 Jan 21.

Typ publikacji:

Journal Article; Research Support, N.I.H., Extramural

MeSH Terms:

Waldenstrom Macroglobulinemia*/diagnosis
Waldenstrom Macroglobulinemia*/drug therapy
Humans ; Immunoglobulin M ; Immunologic Factors ; Immunotherapy ; Rituximab

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 49.

Tytuł:

Incidence and inheritance of hyperphosphorylated paratarg-7 in patients with Waldenstrom's macroglobulinaemia in Sweden.

Autorzy:

Brandefors L; a Department of Radiation Sciences, Oncology , Sunderby Research Unit, Umeå University , Umeå , Sweden.
Lindh J; a Department of Radiation Sciences, Oncology , Sunderby Research Unit, Umeå University , Umeå , Sweden.
Preuss KD; b José-Carreras-Center for Immuno- and Gene Therapy, Department of Internal Medicine I , Saarland University Medical School , Homburg , Germany.
Fadle N; b José-Carreras-Center for Immuno- and Gene Therapy, Department of Internal Medicine I , Saarland University Medical School , Homburg , Germany.
Pfreundschuh M; b José-Carreras-Center for Immuno- and Gene Therapy, Department of Internal Medicine I , Saarland University Medical School , Homburg , Germany.
Kimby E; c Department of Hematology , Karolinska Institute , Stockholm , Sweden.

Pokaż więcej

Źródło:

Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2019 Jun; Vol. 58 (6), pp. 824-827. Date of Electronic Publication: 2019 Mar 19.

Typ publikacji:

Letter

MeSH Terms:

Antigens, Neoplasm/*genetics
Blood Proteins/*genetics
Membrane Proteins/*genetics
Waldenstrom Macroglobulinemia/*epidemiology
Waldenstrom Macroglobulinemia/*genetics
Antigens, Neoplasm/blood ; Antigens, Neoplasm/immunology ; Antigens, Neoplasm/metabolism ; Blood Proteins/immunology ; Blood Proteins/metabolism ; Humans ; Incidence ; Inheritance Patterns ; Male ; Membrane Proteins/blood ; Membrane Proteins/immunology ; Membrane Proteins/metabolism ; Paraproteins/immunology ; Phosphorylation ; Sweden/epidemiology ; Waldenstrom Macroglobulinemia/blood ; Waldenstrom Macroglobulinemia/metabolism

Opinia redakcyjna

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 50.

Tytuł:

Aberrant CXCR4 Signaling at Crossroad of WHIM Syndrome and Waldenstrom's Macroglobulinemia.

Autorzy:

Milanesi S; Humanitas Clinical and Research Center-IRCCS, Via Manzoni 56, I-20089 Rozzano (Milan), Italy.; Department of Medical Biotechnologies and Translational Medicine, University of Milan, Via Fratelli Cervi, I-20090 Segrate (Milan), Italy.
Locati M; Humanitas Clinical and Research Center-IRCCS, Via Manzoni 56, I-20089 Rozzano (Milan), Italy.; Department of Medical Biotechnologies and Translational Medicine, University of Milan, Via Fratelli Cervi, I-20090 Segrate (Milan), Italy.
Borroni EM; Humanitas Clinical and Research Center-IRCCS, Via Manzoni 56, I-20089 Rozzano (Milan), Italy.; Department of Medical Biotechnologies and Translational Medicine, University of Milan, Via Fratelli Cervi, I-20090 Segrate (Milan), Italy.

Pokaż więcej

Źródło:

International journal of molecular sciences [Int J Mol Sci] 2020 Aug 08; Vol. 21 (16). Date of Electronic Publication: 2020 Aug 08.

Typ publikacji:

Journal Article; Review

MeSH Terms:

Signal Transduction*
Primary Immunodeficiency Diseases/*metabolism
Receptors, CXCR4/*metabolism
Waldenstrom Macroglobulinemia/*metabolism
Warts/*metabolism
Humans ; Mutation/genetics ; Primary Immunodeficiency Diseases/genetics ; Protein Multimerization ; Waldenstrom Macroglobulinemia/genetics ; Warts/genetics

SCR Disease Name:

WHIM syndrome

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły